HAEMONETICS CORP — Director's Dealing 2014

Jul 8, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2014-07-07

Reporting Person: GRANADILLO PEDRO P (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-07-07	Common Stock	M	1837.0	$24.96	Acquired	16738	Direct
2014-07-07	Common Stock	S	1837.0	$35.9025	Disposed	14901	Direct
2014-07-07	Common Stock	M	4000.0	$14.9475	Acquired	18901	Direct
2014-07-07	Common Stock	S	4000.0	$36.0063	Disposed	14901	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-07-07	Non-Qualified Stock Option (right to buy)	$14.9475	M	4000.0	Disposed	2014-08-18	Common Stock (4000)	Direct
2014-07-07	Non-Qualified Stock Option (right to buy)	$24.96	M	1837.0	Disposed	2014-08-01	Common Stock (1837)	Direct

Footnotes

F1: Pursuant to a 10b5-1 Plan.

F2: Grant to reporting person of right to buy shares of common stock exercisable immediately.

F3: Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant.